Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database
- 28 October 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 83 (5) , 915-921
Abstract
BACKGROUND: Although the standard of care for glioblastoma remains maximal safe resection followed by chemoradiation, conflicting reports have emerged regarding the importance of the time interval between these 2 treatments. OBJECTIVE: To assess whether differences in the duration between surgery and initiation of chemoradiation for glioblastoma had an impact on overall survival (OS) in a large hospital-based database. METHODS: The National Cancer Database was queried to identify patients diagnosed with glioblastoma between 2010 and 2012 treated with surgery followed by chemoradiation. Patients who received biopsy only were excluded. The time from surgery to initiation of radiation therapy was divided into 4 equal quartiles of ≤24, 25 to 30, 31 to 37, and >37 d. Patient characteristics were compared between groups using Pearson Chi Square and Fisher's Exact test. OS was analyzed via the Kaplan–Meier method and compared via the log-rank test. Univariable and multivariable Cox regression were performed to assess for impact of covariables on OS. RESULTS: A total of 11 652 patients were included in the analysis. Median duration from surgery to radiation was 30 d. On multivariable regression, black race, larger tumor, gross-total resection, methyguanine-methyl transferase (MGMT+), and treatment at an academic facility were associated with a duration >30 d. On multivariable analysis, there were no significant differences when comparing start within 24 d to 25 to 30 d (hazard ratio [HR] 0.96, 95% confidence interval [CI] 0.90-1.01, P = .13) or > 37 d (HR 0.97, 95% CI 0.91-1.03, P = .26), although a small OS improvement was seen if initiated within 31 to 37 d (HR 0.93, 95% CI 0.88-0.99, P = .02). CONCLUSION: There was no clear association between duration from surgery to initiation of chemoradiation on OS.Keywords
This publication has 28 references indexed in Scilit:
- Immortal Time Bias: A Frequently Unrecognized Threat to Validity in the Evaluation of Postoperative RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Impact of radiotherapy delay on survival in glioblastomaClinical and Translational Oncology, 2012
- Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapyJournal of Neuro-Oncology, 2012
- Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?Journal of Neuro-Oncology, 2011
- The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiformeNeuro-Oncology, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group DatabaseJournal of Clinical Oncology, 2009
- Delay in radiotherapy shortens survival in patients with high grade gliomaJournal of Neuro-Oncology, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993